Wells Fargo’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-10
| Closed | -$50 | – | 7218 |
|
2024
Q1 | $50 | Hold |
10
| – | – | ﹤0.01% | 6438 |
|
2023
Q4 | $69 | Sell |
10
-666
| -99% | -$4.6K | ﹤0.01% | 6414 |
|
2023
Q3 | $6.19K | Buy |
676
+66
| +11% | +$604 | ﹤0.01% | 5547 |
|
2023
Q2 | $12.9K | Buy |
610
+9
| +1% | +$190 | ﹤0.01% | 5539 |
|
2023
Q1 | $16.2K | Buy |
601
+201
| +50% | +$5.41K | ﹤0.01% | 5391 |
|
2022
Q4 | $14.2K | Sell |
400
-107
| -21% | -$3.79K | ﹤0.01% | 5089 |
|
2022
Q3 | $114K | Buy |
507
+18
| +4% | +$4.05K | ﹤0.01% | 4251 |
|
2022
Q2 | $93K | Sell |
489
-385
| -44% | -$73.2K | ﹤0.01% | 4426 |
|
2022
Q1 | $218K | Sell |
874
-360
| -29% | -$89.8K | ﹤0.01% | 4635 |
|
2021
Q4 | $192K | Sell |
1,234
-344
| -22% | -$53.5K | ﹤0.01% | 4922 |
|
2021
Q3 | $316K | Buy |
1,578
+1,236
| +361% | +$248K | ﹤0.01% | 4629 |
|
2021
Q2 | $87K | Sell |
342
-179
| -34% | -$45.5K | ﹤0.01% | 5035 |
|
2021
Q1 | $138K | Sell |
521
-365
| -41% | -$96.7K | ﹤0.01% | 5005 |
|
2020
Q4 | $326K | Buy |
886
+343
| +63% | +$126K | ﹤0.01% | 4721 |
|
2020
Q3 | $132K | Sell |
543
-150
| -22% | -$36.5K | ﹤0.01% | 4967 |
|
2020
Q2 | $199K | Buy |
693
+64
| +10% | +$18.4K | ﹤0.01% | 4753 |
|
2020
Q1 | $128K | Sell |
629
-35
| -5% | -$7.12K | ﹤0.01% | 4758 |
|
2019
Q4 | $297K | Sell |
664
-33
| -5% | -$14.8K | ﹤0.01% | 4602 |
|
2019
Q3 | $214K | Buy |
697
+638
| +1,081% | +$196K | ﹤0.01% | 4750 |
|
2019
Q2 | $19K | Sell |
59
-523
| -90% | -$168K | ﹤0.01% | 5445 |
|
2019
Q1 | $244K | Sell |
582
-78
| -12% | -$32.7K | ﹤0.01% | 4654 |
|
2018
Q4 | $200K | Buy |
660
+539
| +445% | +$163K | ﹤0.01% | 4717 |
|
2018
Q3 | $44K | Sell |
121
-4
| -3% | -$1.46K | ﹤0.01% | 5331 |
|
2018
Q2 | $46K | Hold |
125
| – | – | ﹤0.01% | 5340 |
|
2018
Q1 | $37K | Buy |
125
+17
| +16% | +$5.03K | ﹤0.01% | 5347 |
|
2017
Q4 | $45K | Sell |
108
-71
| -40% | -$29.6K | ﹤0.01% | 5298 |
|
2017
Q3 | $59K | Buy |
179
+50
| +39% | +$16.5K | ﹤0.01% | 5149 |
|
2017
Q2 | $31K | Buy |
129
+4
| +3% | +$961 | ﹤0.01% | 5230 |
|
2017
Q1 | $43K | Buy |
125
+25
| +25% | +$8.6K | ﹤0.01% | 5193 |
|
2016
Q4 | $35K | Sell |
100
-1
| -1% | -$350 | ﹤0.01% | 5194 |
|
2016
Q3 | $41K | Buy |
101
+98
| +3,267% | +$39.8K | ﹤0.01% | 5121 |
|
2016
Q2 | $2K | Sell |
3
-22
| -88% | -$14.7K | ﹤0.01% | 5645 |
|
2016
Q1 | $12K | Sell |
25
-12
| -32% | -$5.76K | ﹤0.01% | 5410 |
|
2015
Q4 | $25K | Sell |
37
-1
| -3% | -$676 | ﹤0.01% | 5279 |
|
2015
Q3 | $18K | Buy |
38
+26
| +217% | +$12.3K | ﹤0.01% | 5325 |
|
2015
Q2 | $7K | Sell |
12
-196
| -94% | -$114K | ﹤0.01% | 5667 |
|
2015
Q1 | $1.77M | Sell |
208
-3
| -1% | -$25.5K | ﹤0.01% | 3082 |
|
2014
Q4 | $1.85M | Buy |
211
+15
| +8% | +$132K | ﹤0.01% | 3038 |
|
2014
Q3 | $924K | Buy |
196
+194
| +9,700% | +$915K | ﹤0.01% | 3489 |
|
2014
Q2 | $16K | Buy |
+2
| New | +$16K | ﹤0.01% | 5316 |
|